Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
VRTX Insider Trading and Fund Holdings (VERTEX PHARMACEUTICALS INC / MA) · https://wallstpal.com/stock/vrtx/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
StockCIK 875320

VERTEX PHARMACEUTICALS INC / MA (VRTX): Insider Trades and Fund Holdings

In the past 12 months, VERTEX PHARMACEUTICALS INC / MA insiders reported no open-market purchases and 6 sales worth $4.59M; 6 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months
$0Bought by insiders, 12 months
$4.59MSold by insiders, 12 months
2Tracked funds holding

Timeline: news and trades

Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.

  1. Aug 27, 2026Planned saleBruce I. Sachs (director) filed notice to sell about $662,536 around Aug 27, 2026
  2. Aug 26, 2026CongressRep. David J. Taylor sell $1K–$15K
  3. Aug 3, 2026NewsCompany reported: Quarterly or annual results
  4. Jul 2, 2026Insider saleEVP Duncan McKechnie sold $799,779 under a 10b5-1 plan
  5. Jul 2, 2026Insider saleEVP Ourania Tatsis sold $787,485 under a 10b5-1 plan
  6. Jul 1, 2026Insider saleGeneral Counsel Joy Liu sold $416,244 under a 10b5-1 plan
  7. Jun 30, 2026FundBridgewater Associates cut 19% in Q2 2026 (13F filed Aug 14, 2026)
  8. Jun 30, 2026FundRenaissance Technologies cut 24% in Q2 2026 (13F filed Aug 13, 2026)
  9. Jun 26, 2026Insider saleEVP Carmen Bozic sold $287,570 under a 10b5-1 plan
  10. Jun 18, 2026Insider saleEVP Carmen Bozic sold $471,413 under a 10b5-1 plan
  11. Jun 15, 2026Insider saleEVP Carmen Bozic sold $1.8 million under a 10b5-1 plan
  12. Jan 29, 2026CongressRep. David J. Taylor sell $1K–$15K

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Jul 7, 2026.

Recent VRTX insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHoldingFiling
Jul 7Jul 2Duncan McKechnieEVPEVP▼ SELL10b5-11,541519.00$800K−12%Form 4 ↗
Jul 7Jul 2Ourania TatsisEVPEVP▼ SELL10b5-11,500524.99$787K−3.2%Form 4 ↗
Jul 6Jul 1Joy LiuGeneral CounselGeneral Counsel▼ SELL10b5-1828502.71$416K−4.1%Form 4 ↗
Jun 30Jun 26Carmen BozicEVPEVP▼ SELL10b5-1596482.50$288K−3.7%Form 4 ↗
Jun 23Jun 18Carmen BozicEVPEVP▼ SELL10b5-11,020462.17$471K−6.0%Form 4 ↗
Jun 17Jun 15Carmen BozicEVPEVP▼ SELL10b5-14,062450.00$1.83M−19%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
Duncan McKechnieEVP0$01$800KJul 7, 2026
Ourania TatsisEVP0$01$787KJul 7, 2026
Joy LiuGeneral Counsel0$01$416KJul 6, 2026
Carmen BozicEVP0$03$2.59MJun 30, 2026

Trades by members of Congress

Reported under the STOCK Act. Amounts are ranges from the form. All Congress trades →

Congress trades in VRTX
FiledMemberTypeOwnerAmountTradedDays to reportReport
Sep 5▼ SELLMember$1K–$15KAug 2610PDF ↗
Feb 2▼ SELLMember$1K–$15KJan 294PDF ↗
Sep 2▲ BUYMember$1K–$15KAug 726PDF ↗
Aug 13▼ SELLSpouse$1K–$15KJun 1163latePDF ↗
Aug 13▼ PARTIAL SELLSpouse$1K–$15KJun 1064latePDF ↗
Aug 13▲ BUYSpouse$1K–$15KDec 11245latePDF ↗

Buybacks and executive pay

VERTEX PHARMACEUTICALS INC / MA spent $2.02 billion buying back its own shares in 2025.

From the company's XBRL data filed with the SEC. "Actually paid" is the SEC's pay-versus-performance measure, which counts changes in the value of stock awards. "Value of $100 invested" is the company's cumulative shareholder return as reported, usually measured from five years earlier. See all buybacks and CEO pay across companies.

Filing quality

A All 6 insider trades reported on time. How it is graded

Tracked funds that report VRTX

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

FundQuarterSharesValue% of portfolioChange
Renaissance TechnologiesQ2 2026320,008$159.0M0.22%▼ −24.1%
Bridgewater AssociatesQ2 202610,865$5.40M0.02%▼ −18.7%
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →